Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia
NCT: NCT07399431 · COMPLETED
Brief Summary
Methamphetamine use disorder (MUD) remains a major public health concern in Indonesia, with limited effective treatment options and high relapse rates. Theta Burst Stimulation (TBS) has emerged as a promising adjunctive intervention for reducing craving and improving clinical outcomes. This trial aims to evaluate the efficacy and safety of TBS for MUD. A RCT of 20 subjects was conducted to evalute the efficacy and safety of TBS as an adjunctive treatment to CBT in managing MUD.
Frequently Asked Questions
What is Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia?
Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia is a clinical trial registered under NCT07399431. Current status: COMPLETED.
What is the status of NCT07399431?
The current status of NCT07399431 (Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia) is: COMPLETED.
When did Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia start?
Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia started on 2026-03-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.